Related Experiment Video
Updated: Oct 2, 2025
A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice
Published on: October 13, 2018
Biliary Atresia in 2021: Epidemiology, Screening and Public Policy
Richard A Schreiber1, Sanjiv Harpavat2, Jan B F Hulscher3
1Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Insights
Biliary atresia (BA), a severe newborn liver disease, requires early detection and Kasai portoenterostomy (KPE) surgery for better outcomes. This review examines global public health strategies for BA screening to improve pediatric liver health.
Area of Science:
- Pediatric Hepatology
- Public Health
- Neonatal Diseases
Background:
- Biliary atresia (BA) is a rare but serious liver disease in newborns.
- It is a leading cause of pediatric liver failure and the primary reason for liver transplants in children.
- Early diagnosis and treatment, such as Kasai portoenterostomy (KPE), are crucial for improving patient prognosis.
Purpose of the Study:
- To examine biliary atresia from a global public health perspective.
- To review current national screening programs for BA and their effectiveness.
- To discuss novel screening initiatives and policy challenges for BA detection worldwide.
Main Methods:
- Literature review of global public health data on biliary atresia.
- Analysis of existing national screening programs for BA.
- Examination of policy challenges and case studies from North America, Europe, and Asia.
Main Results:
- Delayed diagnosis and treatment of BA remain a significant global issue.
- Current screening programs show variable impact on patient outcomes.
- Novel screening initiatives are emerging, but implementation faces policy hurdles.
Conclusions:
- Effective global public health strategies and improved screening are essential to reduce morbidity and mortality from biliary atresia.
- Addressing policy challenges is key to implementing successful BA screening programs worldwide.
- Early detection through enhanced screening can improve outcomes for children with BA, potentially reducing the need for liver transplantation.
Abstract:
Biliary atresia (BA) is a rare newborn liver disease with significant morbidity and mortality, especially if not recognized and treated early in life. It is the most common cause of liver-related death in children and the leading indication for liver transplantation in the pediatric population. Timely intervention with a Kasai portoenterostomy (KPE) can significantly improve prognosis. Delayed disease recognition, late patient referral, and untimely surgery remains a worldwide problem. This article will focus on biliary atresia from a global public health perspective, including disease epidemiology, current national screening programs, and their impact on outcome, as well as new and novel BA screening initiatives. Policy challenges for the implementation of BA screening programs will also be discussed, highlighting examples from the North American, European, and Asian experience.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:29Chronic Pancreatitis II: Collaborative Care
Assessment: